Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YER075C | PTP3 | SGDID:S000000877 | PTPRG PTPG |
Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48) |
3.1.3.48 | Homo sapiens | Infantile Myofibromatosis,Fuchs' Endothelial Dystrophy,Lung Cancer Susceptibility 3,Corneal Dystrophy,Schizoaffective Disorder,Breast Cancer,Breast Disease,Lynch Syndrome,Renal Cell Carcinoma, Nonpapillary |
2h4v_b | P23470 | ENSG00000144724 | PTPRG | 100.00 | 3.90E-38 | 3.70E-42 | 342.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPRN ICA3 ICA512 |
Receptor-type tyrosine-protein phosphatase-like N (R-PTP-N) (Islet cell antigen 512) (ICA 512) (Islet cell autoantigen 3) (PTP IA-2) [Cleaved into: ICA512-N-terminal fragment (ICA512-NTF); ICA512-transmembrane fragment (ICA512-TMF); ICA512-cleaved cytosolic fragment (ICA512-CCF)] |
Homo sapiens | Anal Spasm,Cervix Uteri Carcinoma In Situ,Uterus Carcinoma In Situ,Gestational Diabetes,Diabetes Mellitus,Lymphocele,Cervical Large Cell Neuroendocrine Carcinoma,Type 1 Diabetes Mellitus 13,Isthmus Cancer,Cervical Incompetence,Type 1 Diabetes Mellitus 12,Cervix Disease,Hemometra,Pancreatic Colloid Cystadenoma,Parametritis,Autoimmune Disease,Microinvasive Cervical Squamous Cell Carcinoma,Benign Struma Ovarii,Type 1 Diabetes Mellitus,Brachydactyly, Type C,Cervix Carcinoma,Adrenal Cortical Hypofunction,Wissler-Fanconi Syndrome,Fallopian Tube Endometrioid Adenocarcinoma,Pernicious Anemia,Neuronal Ceroid Lipofuscinosis,Type 1 Diabetes Mellitus 2,Type 2 Diabetes Mellitus,Vaginal Discharge,Insulinoma,Pancreatic Cystadenoma,Gastrointestinal System Benign Neoplasm,Bleeding Disorder, Platelet-Type, 17,Maturity-Onset Diabetes Of The Young,Diabetes Mellitus, Ketosis-Prone,Autoimmune Disease Of Endocrine System,Type 1 Diabetes Mellitus 7,Celiac Disease 1 |
2i1y_b | Q16849 | ENSG00000054356 | PTPRN | 100.00 | 1.20E-37 | 1.10E-41 | 334.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YER075C | PTP3 | SGDID:S000000877 | PTPN9 |
Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) |
3.1.3.48 | Homo sapiens | Breast Cancer |
4ge6_a | P43378 | ENSG00000169410 | PTPN9 | 100.00 | 2.00E-37 | 1.90E-41 | 334.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPRB PTPB |
Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP) |
3.1.3.48 | Homo sapiens | Vascular Cancer,Skin Angiosarcoma,Ovarian Angiosarcoma,Glial Tumor,Hyperkalemic Periodic Paralysis,Generalized Epilepsy With Febrile Seizures Plus, Type 1,Angiosarcoma,Generalized Epilepsy With Febrile Seizures Plus |
2hc1_a | P23467 | ENSG00000127329 | PTPRB | 100.00 | 4.00E-35 | 4.00E-39 | 310.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPN14 PEZ PTPD2 |
Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez) |
3.1.3.48 | Homo sapiens | Metatypical Basal Cell Carcinoma,Choanal Atresia And Lymphedema,Wilson-Turner X-Linked Mental Retardation Syndrome |
2bzl_a | Q15678 | ENSG00000152104 | PTPN14 | 100.00 | 2.80E-37 | 2.60E-41 | 336.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPN7 |
Tyrosine-protein phosphatase non-receptor type 7 (EC 3.1.3.48) (Hematopoietic protein-tyrosine phosphatase) (HEPTP) (Protein-tyrosine phosphatase LC-PTP) |
3.1.3.48 | Homo sapiens | Rasopathy |
1zc0_a | P35236 | ENSG00000143851 | PTPN7 | 100.00 | 1.50E-36 | 1.40E-40 | 329.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPRQ |
Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48) |
3.1.3.48 | Homo sapiens | Usher Syndrome, Type Id,Malignant Inflammatory Fibrous Histiocytoma,Retinitis Pigmentosa,Deafness, Autosomal Recessive 39,Deafness, Autosomal Recessive 12,Mesangial Proliferative Glomerulonephritis,Usher Syndrome Type 2,Deafness, Autosomal Dominant 50,Sensorineural Hearing Loss,Usher Syndrome, Type I,Deafness, Autosomal Recessive 84a,Autosomal Dominant Non-Syndromic Sensorineural Deafness Type Dfna,Autosomal Recessive Non-Syndromic Sensorineural Deafness Type Dfnb,Deafness, Autosomal Dominant 73,Branchiootic Syndrome 1,Deafness, Autosomal Recessive 23,Deafness, Autosomal Recessive 42,Deafness, Autosomal Recessive 16,Deafness, Autosomal Recessive 66,Normal Pressure Hydrocephalus,Deafness, Autosomal Dominant 1, With Or Without Thrombocytopenia,Deafness, Autosomal Recessive 61,Usher Syndrome,Autosomal Dominant Nonsyndromic Deafness,Deafness, Autosomal Dominant 22,Vertical Talus, Congenital,Deafness, Autosomal Recessive 22,Deafness, Autosomal Recessive,Deafness, Autosomal Recessive 37,Dyschromatosis Universalis Hereditaria,Paine Syndrome |
4ikc_a | Q9UMZ3 | 100.00 | 5.50E-36 | 5.30E-40 | 316.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
YER075C | PTP3 | SGDID:S000000877 | PTPN1 PTP1B |
Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B) |
3.1.3.48 | Homo sapiens | Primary Mediastinal B-Cell Lymphoma,Diabetes Mellitus,Rasopathy,Myeloproliferative Neoplasm,Leptin Deficiency Or Dysfunction,Ovarian Cancer,Bubonic Plague,Lipid Metabolism Disorder,Noonan Syndrome With Multiple Lentigines,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Hypertension, Essential |
2cm2_a | P18031 | ENSG00000196396 | PTPN1 | 100.00 | 1.20E-35 | 1.10E-39 | 320.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPRJ DEP1 |
Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD antigen CD148) |
3.1.3.48 | Homo sapiens | Interstitial Keratitis,Angiocentric Glioma,Pendred Syndrome,Griscelli Syndrome, Type 3,Colorectal Cancer,Methotrexate-Associated Lymphoproliferation,Thrombocytopenia,Lynch Syndrome,Cd45 Deficiency,Cogan Syndrome,Griscelli Syndrome,Niemann-Pick Disease, Type C1 |
2nz6_a | Q12913 | ENSG00000149177 | PTPRJ | 100.00 | 3.60E-38 | 3.40E-42 | 341.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPN4 |
Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1) |
3.1.3.48 | Homo sapiens | Rabies,Disease Of Mental Health |
2i75_a | P29074 | ENSG00000088179 | PTPN4 | 100.00 | 1.10E-37 | 1.10E-41 | 339.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | Protein-tyrosine-phosphatase (EC 3.1.3.48) |
Protein-tyrosine-phosphatase (EC 3.1.3.48) |
3.1.3.48 | Rattus norvegicus | 3i36_a | Q62884 | 100.00 | 1.90E-37 | 1.80E-41 | 339.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER075C | PTP3 | SGDID:S000000877 | PTPRF LAR |
Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR) |
3.1.3.48 | Homo sapiens | Isolated Congenital Breast Hypoplasia/Aplasia,Van Maldergem Syndrome 1,Pheochromocytoma,Breasts And/Or Nipples, Aplasia Or Hypoplasia Of, 2,Ureterocele |
1lar_a | P10586 | ENSG00000142949 | PTPRF | 99.90 | 7.10E-34 | 6.90E-38 | 329.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPN12 |
Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1) |
3.1.3.48 | Homo sapiens | Leiomyomatosis,Charcot-Marie-Tooth Disease,Colorectal Cancer,Pyogenic Sterile Arthritis, Pyoderma Gangrenosum, And Acne,Lynch Syndrome,Myopathy, Centronuclear, 2 |
5hde_a | Q05209 | ENSG00000127947 | PTPN12 | 100.00 | 6.20E-38 | 5.90E-42 | 338.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPRZ1 HTPZP2 PTPRZ PTPRZ2 PTPZ |
Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48) (Protein-tyrosine phosphatase receptor type Z polypeptide 1) (Protein-tyrosine phosphatase receptor type Z polypeptide 2) (R-PTP-zeta-2) |
3.1.3.48 | Homo sapiens | Oligodendroglioma,Hyperkalemic Periodic Paralysis,Generalized Epilepsy With Febrile Seizures Plus, Type 1,Generalized Epilepsy With Febrile Seizures Plus |
5awx_a | P23471 | ENSG00000106278 | PTPRZ1 | 100.00 | 3.80E-36 | 3.70E-40 | 320.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | Tb10.70.0070 |
Tb10.70.0070 |
3.1.3.48 | Trypanosoma brucei | 3m4u_a | Q38AT7 | 99.90 | 5.50E-32 | 5.30E-36 | 290.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER075C | PTP3 | SGDID:S000000877 | PTPRT KIAA0283 |
Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho) |
3.1.3.48 | Homo sapiens | Colorectal Cancer,Schizophrenia,Autism Spectrum Disorder,Autism |
2ooq_a | O14522 | ENSG00000196090 | PTPRT | 100.00 | 1.10E-35 | 1.00E-39 | 314.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPN5 |
Tyrosine-protein phosphatase non-receptor type 5 (EC 3.1.3.48) (Neural-specific protein-tyrosine phosphatase) (Striatum-enriched protein-tyrosine phosphatase) (STEP) |
3.1.3.48 | Homo sapiens | Kagami-Ogata Syndrome,Viral Gastritis,Phencyclidine Abuse,Disease Of Mental Health,Fragile X Syndrome |
2bv5_a | P54829 | ENSG00000110786 | PTPN5 | 99.90 | 1.40E-33 | 1.30E-37 | 298.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPRE |
Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48) |
3.1.3.48 | Homo sapiens | 6d3f_a | P23469 | ENSG00000132334 | PTPRE | 99.90 | 6.80E-34 | 6.60E-38 | 300.20 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YER075C | PTP3 | SGDID:S000000877 | PTPRO GLEPP1 PTPU2 |
Receptor-type tyrosine-protein phosphatase O (R-PTP-O) (EC 3.1.3.48) (Glomerular epithelial protein 1) (Protein tyrosine phosphatase U2) (PTP-U2) (PTPase U2) |
3.1.3.48 | Homo sapiens | Nephrotic Syndrome,Galloway-Mowat Syndrome,Genetic Steroid-Resistant Nephrotic Syndrome,Familial Nephrotic Syndrome,Focal Segmental Glomerulosclerosis,Crescentic Glomerulonephritis,Alport Syndrome,Focal Segmental Glomerulosclerosis 1,Nephrotic Syndrome, Type 6,Wilms Tumor 1 |
2gjt_a | Q16827 | ENSG00000151490 | PTPRO | 99.90 | 9.80E-34 | 9.40E-38 | 301.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | Ptp10D CG1817 |
Tyrosine-protein phosphatase 10D (EC 3.1.3.48) (Receptor-linked protein-tyrosine phosphatase 10D) (DPTP10D) |
3.1.3.48 | Drosophila melanogaster | 3s3e_a | P35992 | 100.00 | 1.80E-36 | 1.70E-40 | 326.60 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |||
YER075C | PTP3 | SGDID:S000000877 | PTPN22 PTPN8 |
Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP) |
3.1.3.48 | Homo sapiens | Psoriasis,Lymphopenia,Myopathy,Palindromic Rheumatism,Achalasia,Diabetes Mellitus,Multifocal Motor Neuropathy,Chronic Mucocutaneous Candidiasis,Autoimmune Polyendocrine Syndrome, Type Ii,Thyroiditis,Type 1 Diabetes Mellitus 12,Latent Autoimmune Diabetes In Adults,Primary Biliary Cholangitis,Pediatric Systemic Lupus Erythematosus,Vogt-Koyanagi-Harada Disease,Graves' Disease,Alopecia Areata,Granulomatosis With Polyangiitis,Autoimmune Disease,Behcet Syndrome,Arthritis,Central Nervous System Vasculitis,Type 1 Diabetes Mellitus,Aplastic Anemia,Scleritis,Adrenal Cortical Hypofunction,Crohn'S Disease,Lupus Erythematosus,Anca-Associated Vasculitis,Pernicious Anemia,Oligoarticular Juvenile Idiopathic Arthritis,Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis,Brucellosis,Bone Inflammation Disease,Turner Syndrome,Thrombocytopenia,Rheumatoid Arthritis,Type 1 Diabetes Mellitus 2,Multiple Sclerosis,Adrenal Cortex Disease,Type 1 Diabetes Mellitus 18,Hypoadrenocorticism, Familial,Immunodeficiency 31c,Inflammatory Bowel Disease,Temporal Arteritis,Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 1,Hashimoto Thyroiditis,Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 6,Autoimmune Disease Of Endocrine System,Autoimmune Disease Of Musculoskeletal System,Autoimmune Disease Of Skin And Connective Tissue,Psoriatic Arthritis,Systemic Lupus Erythematosus,Penicillin Allergy,Type 1 Diabetes Mellitus 3,Type 1 Diabetes Mellitus 5,Celiac Disease 1,Type 1 Diabetes Mellitus 8 |
2p6x_a | Q9Y2R2 | ENSG00000134242 | PTPN22 | 100.00 | 6.20E-36 | 5.90E-40 | 322.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | Ptpra Lrp Ptpa |
Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48) (LCA-related phosphatase) (PTPTY-28) |
3.1.3.48 | Mus musculus | 1p15_b | P18052 | 99.90 | 1.30E-33 | 1.30E-37 | 292.10 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YER075C | PTP3 | SGDID:S000000877 | PTPRR ECPTP PTPRQ |
Receptor-type tyrosine-protein phosphatase R (R-PTP-R) (EC 3.1.3.48) (Ch-1PTPase) (NC-PTPCOM1) (Protein-tyrosine phosphatase PCPTP1) |
3.1.3.48 | Homo sapiens | Usher Syndrome, Type Id,Myopia,Refractive Error,Usher Syndrome Type 2,Deafness, Autosomal Recessive 84a,Deafness, Autosomal Dominant 1, With Or Without Thrombocytopenia,Usher Syndrome,Autosomal Dominant Nonsyndromic Deafness,Dyschromatosis Universalis Hereditaria |
2a8b_a | Q15256 | ENSG00000153233 | PTPRR | 99.90 | 1.00E-33 | 9.90E-38 | 300.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPN6 HCP PTP1C |
Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1) |
3.1.3.48 | Homo sapiens | Neutrophilic Dermatosis, Acute Febrile,Leishmaniasis,Myeloproliferative Neoplasm,Leukemia, Acute Lymphoblastic,Polycythemia,Subcorneal Pustular Dermatosis,Breast Adenocarcinoma,Severe Congenital Neutropenia,Acute Promyelocytic Leukemia,Cd45 Deficiency,Polycythemia Vera |
2b3o_a | P29350 | ENSG00000111679 | PTPN6 | 99.90 | 7.10E-34 | 7.00E-38 | 325.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPN18 BDP1 |
Tyrosine-protein phosphatase non-receptor type 18 (EC 3.1.3.48) (Brain-derived phosphatase) |
3.1.3.48 | Homo sapiens | 2oc3_a | Q99952 | ENSG00000072135 | PTPN18 | 100.00 | 2.00E-37 | 1.90E-41 | 333.20 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YER075C | PTP3 | SGDID:S000000877 | yopH yop51 |
Tyrosine-protein phosphatase YopH (EC 3.1.3.48) (Virulence protein) |
3.1.3.48 | Yersinia enterocolitica | 1yts_a | P15273 | 99.90 | 1.00E-31 | 9.60E-36 | 284.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YER075C | PTP3 | SGDID:S000000877 | PTPN11 PTP2C SHPTP2 |
Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3) |
3.1.3.48 | Homo sapiens | Tricuspid Valve Insufficiency,Metachondromatosis,Heart Septal Defect,Heart Disease,Learning Disability,Endometrial Cancer,Pfeiffer Syndrome,Childhood Acute Lymphocytic Leukemia,Lung Cancer Susceptibility 3,Chronic Myelomonocytic Leukemia,Pulmonary Valve Stenosis,Atrial Heart Septal Defect,Leukemia, Chronic Myeloid,Plasma Cell Neoplasm,Juvenile Xanthogranuloma,Neurofibromatosis-Noonan Syndrome,B-Lymphoblastic Leukemia/Lymphoma,Hypertrophic Cardiomyopathy,Rasopathy,Noonan Syndrome-Like Disorder With Loose Anagen Hair,Keratosis Pilaris Atrophicans Faciei,Specific Learning Disability,Costello Syndrome,Hemorrhagic Disease,Essential Thrombocythemia,Myeloproliferative Neoplasm,Neutropenia,Pulmonary Interstitial Glycogenosis,Neurofibromatosis, Type I,Aggressive Systemic Mastocytosis,Villonodular Synovitis,Leukemia,Neuroblastoma,Pilocytic Astrocytoma,Gliofibroma,Cryptorchidism, Unilateral Or Bilateral,Skin Granular Cell Tumor,Childhood Leukemia,Pseudo-Turner Syndrome,Inherited Cancer-Predisposing Syndrome,Testicular Spermatocytic Seminoma,Leukemia, Acute Myeloid,Noonan Syndrome 1,Bone Marrow Cancer,Myelodysplastic/Myeloproliferative Neoplasm,Hematologic Cancer,Leukemia, Acute Lymphoblastic,Noonan Syndrome And Noonan-Related Syndrome,Autoimmune Disease,Dilated Cardiomyopathy,Sensorineural Hearing Loss,Pigmented Villonodular Synovitis,Brain Cancer,Acute Megakaryoblastic Leukemia In Down Syndrome,Enchondromatosis, Multiple, Ollier Type,Noonan Syndrome-Like Disorder With Loose Anagen Hair 2,Myeloid Leukemia,Neurofibromatosis,Breast Cancer,Protein-Losing Enteropathy,Patent Foramen Ovale,Mature Cataract,Colorectal Cancer,Cystic Lymphangioma,Pulmonary Valve Disease,Hepatocellular Carcinoma,Pectus Excavatum,Cardiofaciocutaneous Syndrome 1,Microcephaly,Embryonal Rhabdomyosarcoma,Rhabdomyosarcoma,Noonan Syndrome With Multiple Lentigines,Noonan Syndrome-Like Disorder With Or Without Juvenile Myelomonocytic Leukemia,Cherubism,Noonan Syndrome 3,Gastric Cancer,Cone-Rod Dystrophy 2,Systemic Mastocytosis,Disease Of Mental Health,Body Mass Index Quantitative Trait Locus 11,Contractures, Pterygia, And Spondylocarpotarsal Fusion Syndrome 1a,Thrombocytopenia,Gastric Adenocarcinoma,Lung Squamous Cell Carcinoma,Ventricular Tachycardia, Catecholaminergic Polymorphic, 1, With Or Without Atrial Dysfunction And/Or Dilated Cardiomyopathy,Arrhythmogenic Right Ventricular Cardiomyopathy,Legius Syndrome,Hypertelorism, Microtia, Facial Clefting Syndrome,Odontochondrodysplasia,Leopard Syndrome 2,Severe Congenital Neutropenia,Tetralogy Of Fallot,Myelodysplastic Syndrome,Tumor Predisposition Syndrome,Down Syndrome,Cutaneous Telangiectasia And Cancer Syndrome, Familial,Meningioma, Familial,Autism Spectrum Disorder,Lymphoma,Patent Ductus Arteriosus 1,Lymphoproliferative Syndrome, X-Linked, 1,Body Dysmorphic Disorder,Scoliosis,Lentigines,Noonan Syndrome-Like Disorder With Loose Anagen Hair 1,Ptosis,Leopard Syndrome 1,Leukemia, Chronic Lymphocytic,Juvenile Myelomonocytic Leukemia,Atrial Septal Defect 2,Myeloma, Multiple,Lymphoproliferative Syndrome,Neuroblastoma 1,Lung Cancer,Helicobacter Pylori Infection,Polycythemia Vera |
3b7o_a | Q06124 | ENSG00000179295 | PTPN11 | 100.00 | 1.80E-37 | 1.70E-41 | 335.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | PTPN3 PTPH1 |
Tyrosine-protein phosphatase non-receptor type 3 (EC 3.1.3.48) (Protein-tyrosine phosphatase H1) (PTP-H1) |
3.1.3.48 | Homo sapiens | Type 1 Diabetes Mellitus,Autoimmune Lymphoproliferative Syndrome,Breast Cancer,Non-Functioning Pituitary Adenoma,Hyperinsulinemic Hypoglycemia, Familial, 5,Cholangiocarcinoma,Fragile X Syndrome,Scott Syndrome |
4ri5_a | P26045 | ENSG00000070159 | PTPN3 | 100.00 | 2.10E-38 | 2.00E-42 | 343.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | Tc00.1047053510187.234 |
Tc00.1047053510187.234 |
Trypanosoma cruzi | 4az1_a | Q4E4C8 | 99.90 | 1.30E-32 | 1.20E-36 | 294.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YER075C | PTP3 | SGDID:S000000877 | PTPRC CD45 |
Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45) |
3.1.3.48 | Homo sapiens | X-Linked Recessive Disease,Reticulum Cell Sarcoma,Severe Combined Immunodeficiency,Childhood Acute Lymphocytic Leukemia,Lymphosarcoma,Lymphoblastic Lymphoma,Listeriosis,Retinitis Pigmentosa,Hair Disease,Pancreas Lymphoma,Kagami-Ogata Syndrome,Neuroendocrine Carcinoma,Vulvar Apocrine Adenocarcinoma,Signet Ring Basal Cell Carcinoma,Malignant Fibrous Histiocytoma,Leukemia, Chronic Myeloid,Heart Lymphoma,Diabetes Mellitus,Autoimmune Disease Of The Nervous System,Barre-Lieou Syndrome,B-Lymphoblastic Leukemia/Lymphoma,Benign Giant Cell Tumor,Bone Lymphoma,Desmoplastic Small Round Cell Tumor,Autoimmune Hepatitis,Leukocyte Disease,Glomangiomatosis,Dendritic Cell Tumor,Encephalitis,T-Cell Non-Hodgkin Lymphoma,Mature B-Cell Neoplasm,B-Cell Lymphoma,Cobblestone Retinal Degeneration,Epiglottis Neoplasm,Endometrial Small Cell Carcinoma,Plasmablastic Lymphoma,T-Cell Lymphoblastic Leukemia/Lymphoma,Primitive Neuroectodermal Tumor Of The Cervix Uteri,Blood Platelet Disease,Benign Mastocytoma,Diamond-Blackfan Anemia 1,Bladder Small Cell Carcinoma,Monoclonal Gammopathy Of Uncertain Significance,Lymphatic System Disease,Retroperitoneum Carcinoma,Cerebellopontine Angle Primitive Neuroectodermal Tumor,Villonodular Synovitis,Lymph Node Disease,Blood Coagulation Disease,Glomeruloid Hemangioma,Tibial Nerve Palsy,Leukemia, Acute Myeloid,Bone Marrow Cancer,Gallbladder Lymphoma,Extraosseous Ewings Sarcoma-Primitive Neuroepithelial Tumor,Leber Plus Disease,Retroperitoneal Fibrosis,Leukemia, Acute Lymphoblastic,Combined Immunodeficiency,Microinvasive Cervical Squamous Cell Carcinoma,Dilated Cardiomyopathy,Myoepithelioma,Nodular Tenosynovitis,Pigmented Villonodular Synovitis,Actinomycosis,Human Immunodeficiency Virus Infectious Disease,Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, Nk Cell-Positive,Epithelioid Leiomyosarcoma,Small Intestinal Sarcoma,Thymus Gland Disease,Idiopathic Interstitial Pneumonia,Type 1 Diabetes Mellitus,Breast Lipoma,Cranial Nerve Malignant Neoplasm,Reticulosarcoma,Autoimmune Lymphoproliferative Syndrome,Hodgkin'S Lymphoma, Lymphocytic-Histiocytic Predominance,Brachydactyly, Type C,Immune System Disease,Epididymis Cancer,Epididymis Adenocarcinoma,Mediastinal Cancer,Myeloid Sarcoma,Prostate Neuroendocrine Neoplasm,T-Cell Acute Lymphoblastic Leukemia,Histiocytic And Dendritic Cell Cancer,Malignant Giant Cell Tumor Of Soft Parts,Breast Cancer,Peripheral Nervous System Disease,Cystadenocarcinoma,Cerebral Lipidosis,Ectodermal Dysplasia 10b, Hypohidrotic/Hair/Tooth Type, Autosomal Recessive,Primary Cutaneous Anaplastic Large Cell Lymphoma,Demyelinating Disease,Bicipital Tenosynovitis,Cataract 4, Multiple Types,Rhabdomyosarcoma,Hepatitis C Virus,Thymoma,Thymus Cancer,Multifocal Osteogenic Sarcoma,T Cell Deficiency,Cranial Nerve Neoplasm,Histiocytosis,Skin Carcinoma,Omenn Syndrome,Cone-Rod Dystrophy 2,Disease Of Mental Health,Retinitis Pigmentosa 24,Brittle Bone Disorder,Conventional Fibrosarcoma,Mucinous Cystadenocarcinoma,Pulmonary Fibrosis, Idiopathic,Macular Degeneration, Age-Related, 8,Olfactory Nerve Neoplasm,Rhabdoid Cancer,Olfactory Neuroblastoma,Integumentary System Disease,Retinitis Pigmentosa 23,Retinitis Pigmentosa 10,Plasmacytoma,Multiple Sclerosis,Diclofenac Allergy,Sarcoidosis 1,Drug-Induced Lupus Erythematosus,Disease By Infectious Agent,Langerhans Cell Histiocytosis,Merkel Cell Carcinoma,Lymphoma, Non-Hodgkin, Familial,Lymphoma, Hodgkin, Classic,Primary Bacterial Infectious Disease,Small Cell Cancer Of The Lung,Spastic Paraplegia 3, Autosomal Dominant,Hypotrichosis 1,Parkinson Disease 4, Autosomal Dominant,Hereditary Lymphedema,Inflammatory Bowel Disease,Immune Deficiency Disease,Lymphoma, Mucosa-Associated Lymphoid Type,Small Cell Carcinoma,X-Linked Monogenic Disease,Anaplastic Large Cell Lymphoma,Diffuse Large B-Cell Lymphoma,Ewing Sarcoma,Mantle Cell Lymphoma,Peripheral T-Cell Lymphoma,Mental Retardation, Autosomal Dominant 36,Acute Promyelocytic Leukemia,Gastrointestinal Carcinoma,Duodenum Adenoma,Wilms Tumor 1,Autoimmune Disease Of Central Nervous System,Cd45 Deficiency,Ectodermal Dysplasia 1, Hypohidrotic, X-Linked,Hypertension, Essential,Autoimmune Disease Of Musculoskeletal System,Lymphoma,Metachromatic Leukodystrophy,Leukemia, Chronic Lymphocytic,Autosomal Dominant Non-Syndromic Intellectual Disability,Systemic Lupus Erythematosus,Mycobacterium Tuberculosis 1,Pelizaeus-Merzbacher Disease,Myeloma, Multiple,Lymphoproliferative Syndrome,Waldenstroem'S Macroglobulinemia,Hereditary Lymphedema I,Lung Cancer,Celiac Disease 1,Budd-Chiari Syndrome |
1ygr_a | P08575 | ENSG00000081237 | PTPRC | 100.00 | 1.90E-35 | 1.80E-39 | 347.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YER075C | PTP3 | SGDID:S000000877 | sptP STM2878 |
Secreted effector protein SptP [Includes: GTPase-activating protein (GAP); Tyrosine-protein phosphatase (EC 3.1.3.48)] |
3.1.3.48 | Salmonella typhimurium | 1g4u_s | P74873 | 100.00 | 3.60E-35 | 3.30E-39 | 327.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |